Search research articles
Contact Us
Filters
Showing results (151-160 of 235) with videos related to
Page
of 24
Sort By:
The Oncologist
|
August 22, 2018
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors
David R D'Adamo, Mark A Dickson, Mary L Keohan, et al.
Eclinicalmedicine
|
September 21, 2023
An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study
Dimitris Bertsimas, Georgios Antonios Margonis, Seehanah Tang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 19, 2021
Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial
Robin L Jones, César Serrano, Margaret von Mehren, et al.
Cancer Discovery
|
January 10, 2015
Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth
Leili Ran, Inna Sirota, Zhen Cao, et al.
The American Journal of Surgical Pathology
|
March 20, 2018
NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma
Sarah Chiang, Paolo Cotzia, David M Hyman, et al.
Cancer Medicine
|
June 21, 2026
Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials
Adel Shahnam, Kristen DiConza, Simran Jasnani, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 12, 2017
Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma
Neel P Chudgar, Murray F Brennan, Rodrigo R Munhoz, et al.
The Oncologist
|
July 4, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study
Andrew J Wagner, William D Tap, Sebastian Bauer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2015
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas
Mrinal Gounder, Ved Desai, Deborah Kuk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2023
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib
C Serrano, S Bauer, D Gómez-Peregrina, et al.
Page
of 24
Search research articles
Search
Showing results (151-160 of 235) with videos related to
Sort By:
Page
of 24
The Oncologist
|
August 22, 2018
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors
David R D'Adamo, Mark A Dickson, Mary L Keohan, et al.
Eclinicalmedicine
|
September 21, 2023
An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study
Dimitris Bertsimas, Georgios Antonios Margonis, Seehanah Tang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 19, 2021
Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial
Robin L Jones, César Serrano, Margaret von Mehren, et al.
Cancer Discovery
|
January 10, 2015
Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth
Leili Ran, Inna Sirota, Zhen Cao, et al.
The American Journal of Surgical Pathology
|
March 20, 2018
NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma
Sarah Chiang, Paolo Cotzia, David M Hyman, et al.
Cancer Medicine
|
June 21, 2026
Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials
Adel Shahnam, Kristen DiConza, Simran Jasnani, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 12, 2017
Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma
Neel P Chudgar, Murray F Brennan, Rodrigo R Munhoz, et al.
The Oncologist
|
July 4, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study
Andrew J Wagner, William D Tap, Sebastian Bauer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2015
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas
Mrinal Gounder, Ved Desai, Deborah Kuk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2023
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib
C Serrano, S Bauer, D Gómez-Peregrina, et al.
Page
of 24